LRRK2 and Parkinson disease: Variants in LRRK2 associated with increased kinase activity are proposed to contribute to PD pathogenesis, and growing evidence suggests LRRK2 activity is similarly elevated in patients with sporadic disease, suggesting this may represent a central node of dysfunction in PD [17, 71].